We asked readers what they think about companies that are relying more on artificial intelligence to screen candidates. Are the trade-offs acceptable?
Related Posts
Basic Materials Roundup: Market Talk
Find insight on Fresnillo, Akzo Nobel and more in the latest Market Talks covering Basic Materials.
Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion
Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.
Deutsche Bank Shares Climb on Profit Boost From Postbank Settlement
Deutsche Bank said it reached agreements with a large share of plaintiffs to settle a long-running legal case over the price of the acquisition of […]